US Stock MarketDetailed Quotes

Capricor Therapeutics (CAPR)

Watchlist
  • 24.170
  • 0.0000.00%
Close Jan 22 16:00 ET
  • 24.020
  • -0.150-0.62%
Pre 09:18 ET
1.31BMarket Cap-13.81P/E (TTM)

Capricor Therapeutics (CAPR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
-11.55%22.27M
-7.92%11.13M
-63.44%2.26M
1.38%3.97M
64.29%4.91M
886.81%25.18M
1,159.30%12.09M
Operating revenue
--0
--0
--0
-11.55%22.27M
-7.92%11.13M
-63.44%2.26M
1.38%3.97M
64.29%4.91M
886.81%25.18M
1,159.30%12.09M
Cost of revenue
Gross profit
Operating expense
72.11%26.28M
78.11%27.72M
64.66%24.98M
31.63%64.84M
40.83%18.83M
17.02%15.27M
33.42%15.56M
35.82%15.17M
52.74%49.26M
48.12%13.37M
Selling and administrative expenses
71.86%5.68M
86.80%5.42M
49.94%5.88M
14.96%14.22M
24.36%4.09M
13.60%3.3M
5.49%2.9M
14.69%3.92M
19.83%12.37M
22.68%3.29M
-General and administrative expense
71.86%5.68M
86.80%5.42M
49.94%5.88M
14.96%14.22M
24.36%4.09M
13.60%3.3M
5.49%2.9M
14.69%3.92M
19.83%12.37M
22.68%3.29M
Research and development costs
72.42%20.36M
76.31%22.05M
70.40%18.92M
37.10%49.97M
46.43%14.55M
17.74%11.81M
41.82%12.5M
44.89%11.1M
67.06%36.45M
59.51%9.94M
Depreciation amortization depletion
54.57%247.99K
61.22%252.79K
25.12%190.49K
47.21%651.23K
30.71%181.75K
41.14%160.44K
61.16%156.8K
64.85%152.24K
293.04%442.37K
--139.04K
-Depreciation and amortization
54.57%247.99K
61.22%252.79K
25.12%190.49K
47.21%651.23K
30.71%181.75K
41.14%160.44K
61.16%156.8K
64.85%152.24K
293.04%442.37K
--139.04K
Operating profit
-102.03%-26.28M
-139.14%-27.72M
-143.36%-24.98M
-76.78%-42.56M
-500.79%-7.7M
-89.52%-13.01M
-49.62%-11.59M
-25.43%-10.27M
18.92%-24.08M
84.12%-1.28M
Net non-operating interest income expense
Other net income (expense)
278.11%1.71M
205.75%1.81M
25.33%591.35K
17.17%2.1M
11.95%581.24K
-4.40%453.15K
55.36%591.44K
13.30%471.83K
164.12%1.79M
50.30%519.2K
Gain on sale of security
278.13%1.71M
203.22%1.79M
54.62%729.54K
27.44%2.2M
51.83%686.57K
-5.47%453.15K
55.36%591.44K
13.30%471.83K
231.46%1.73M
19.09%452.2K
Special income (charges)
---6.85K
--0
---150.67K
-1,767.32%-112.81K
-17,174.89%-112.81K
--0
--0
--0
82.37%-6.04K
98.09%-653
-Gain on sale of property,plant,equipment
---6.85K
--0
---150.67K
-1,767.32%-112.81K
-17,174.89%-112.81K
--0
--0
--0
82.37%-6.04K
98.09%-653
Other non- operating income (expenses)
--6.74K
--14.99K
--12.49K
-88.96%7.47K
----
----
----
----
-64.50%67.66K
----
Income before tax
-95.68%-24.57M
-135.56%-25.91M
-149.04%-24.39M
-81.57%-40.47M
-833.83%-7.12M
-96.49%-12.56M
-49.32%-11M
-26.08%-9.79M
23.20%-22.29M
90.13%-762.09K
Income tax
Net income
-95.68%-24.57M
-135.56%-25.91M
-149.04%-24.39M
-81.57%-40.47M
-833.83%-7.12M
-96.49%-12.56M
-49.32%-11M
-26.08%-9.79M
23.20%-22.29M
90.13%-762.09K
Net income continuous Operations
-95.68%-24.57M
-135.56%-25.91M
-149.04%-24.39M
-81.57%-40.47M
-833.83%-7.12M
-96.49%-12.56M
-49.32%-11M
-26.08%-9.79M
23.20%-22.29M
90.13%-762.09K
Minority interest income
Net income attributable to the parent company
-95.68%-24.57M
-135.56%-25.91M
-149.04%-24.39M
-81.57%-40.47M
-833.83%-7.12M
-96.49%-12.56M
-49.32%-11M
-26.08%-9.79M
23.20%-22.29M
90.13%-762.09K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-95.68%-24.57M
-135.56%-25.91M
-149.04%-24.39M
-81.57%-40.47M
-833.83%-7.12M
-96.49%-12.56M
-49.32%-11M
-26.08%-9.79M
23.20%-22.29M
90.13%-762.09K
Basic earnings per share
-42.11%-0.54
-62.86%-0.57
-70.97%-0.53
-38.55%-1.15
-900.00%-0.16
-52.00%-0.38
-20.69%-0.35
0.00%-0.31
29.66%-0.83
106.45%0.02
Diluted earnings per share
-42.11%-0.54
-62.86%-0.57
-70.97%-0.53
-38.55%-1.15
-900.00%-0.16
-52.00%-0.38
-20.69%-0.35
0.00%-0.31
29.66%-0.83
106.45%0.02
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 000-11.55%22.27M-7.92%11.13M-63.44%2.26M1.38%3.97M64.29%4.91M886.81%25.18M1,159.30%12.09M
Operating revenue --0--0--0-11.55%22.27M-7.92%11.13M-63.44%2.26M1.38%3.97M64.29%4.91M886.81%25.18M1,159.30%12.09M
Cost of revenue
Gross profit
Operating expense 72.11%26.28M78.11%27.72M64.66%24.98M31.63%64.84M40.83%18.83M17.02%15.27M33.42%15.56M35.82%15.17M52.74%49.26M48.12%13.37M
Selling and administrative expenses 71.86%5.68M86.80%5.42M49.94%5.88M14.96%14.22M24.36%4.09M13.60%3.3M5.49%2.9M14.69%3.92M19.83%12.37M22.68%3.29M
-General and administrative expense 71.86%5.68M86.80%5.42M49.94%5.88M14.96%14.22M24.36%4.09M13.60%3.3M5.49%2.9M14.69%3.92M19.83%12.37M22.68%3.29M
Research and development costs 72.42%20.36M76.31%22.05M70.40%18.92M37.10%49.97M46.43%14.55M17.74%11.81M41.82%12.5M44.89%11.1M67.06%36.45M59.51%9.94M
Depreciation amortization depletion 54.57%247.99K61.22%252.79K25.12%190.49K47.21%651.23K30.71%181.75K41.14%160.44K61.16%156.8K64.85%152.24K293.04%442.37K--139.04K
-Depreciation and amortization 54.57%247.99K61.22%252.79K25.12%190.49K47.21%651.23K30.71%181.75K41.14%160.44K61.16%156.8K64.85%152.24K293.04%442.37K--139.04K
Operating profit -102.03%-26.28M-139.14%-27.72M-143.36%-24.98M-76.78%-42.56M-500.79%-7.7M-89.52%-13.01M-49.62%-11.59M-25.43%-10.27M18.92%-24.08M84.12%-1.28M
Net non-operating interest income expense
Other net income (expense) 278.11%1.71M205.75%1.81M25.33%591.35K17.17%2.1M11.95%581.24K-4.40%453.15K55.36%591.44K13.30%471.83K164.12%1.79M50.30%519.2K
Gain on sale of security 278.13%1.71M203.22%1.79M54.62%729.54K27.44%2.2M51.83%686.57K-5.47%453.15K55.36%591.44K13.30%471.83K231.46%1.73M19.09%452.2K
Special income (charges) ---6.85K--0---150.67K-1,767.32%-112.81K-17,174.89%-112.81K--0--0--082.37%-6.04K98.09%-653
-Gain on sale of property,plant,equipment ---6.85K--0---150.67K-1,767.32%-112.81K-17,174.89%-112.81K--0--0--082.37%-6.04K98.09%-653
Other non- operating income (expenses) --6.74K--14.99K--12.49K-88.96%7.47K-----------------64.50%67.66K----
Income before tax -95.68%-24.57M-135.56%-25.91M-149.04%-24.39M-81.57%-40.47M-833.83%-7.12M-96.49%-12.56M-49.32%-11M-26.08%-9.79M23.20%-22.29M90.13%-762.09K
Income tax
Net income -95.68%-24.57M-135.56%-25.91M-149.04%-24.39M-81.57%-40.47M-833.83%-7.12M-96.49%-12.56M-49.32%-11M-26.08%-9.79M23.20%-22.29M90.13%-762.09K
Net income continuous Operations -95.68%-24.57M-135.56%-25.91M-149.04%-24.39M-81.57%-40.47M-833.83%-7.12M-96.49%-12.56M-49.32%-11M-26.08%-9.79M23.20%-22.29M90.13%-762.09K
Minority interest income
Net income attributable to the parent company -95.68%-24.57M-135.56%-25.91M-149.04%-24.39M-81.57%-40.47M-833.83%-7.12M-96.49%-12.56M-49.32%-11M-26.08%-9.79M23.20%-22.29M90.13%-762.09K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -95.68%-24.57M-135.56%-25.91M-149.04%-24.39M-81.57%-40.47M-833.83%-7.12M-96.49%-12.56M-49.32%-11M-26.08%-9.79M23.20%-22.29M90.13%-762.09K
Basic earnings per share -42.11%-0.54-62.86%-0.57-70.97%-0.53-38.55%-1.15-900.00%-0.16-52.00%-0.38-20.69%-0.350.00%-0.3129.66%-0.83106.45%0.02
Diluted earnings per share -42.11%-0.54-62.86%-0.57-70.97%-0.53-38.55%-1.15-900.00%-0.16-52.00%-0.38-20.69%-0.350.00%-0.3129.66%-0.83106.45%0.02
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More